Status:
COMPLETED
Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Oslo University Hospital
Conditions:
Aortic Valve Stenosis
Myocardial Fibrosis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study is part of a research project in which new ultrasound-based techniques will be examined to improve clinical decision making for patients with aortic stenosis. These patients could develop i...
Eligibility Criteria
Inclusion
- Able to undergo protocolled investigations
- Patients: Mild, moderate or severe AS
Exclusion
- Renal insufficiency
- Previously myocardial infarction (ECG, echocardiogram or hospital record)
- Severe valvular heart disease (except patients)
- Other cardiac disease known to cause myocardial fibrosis
- Severe hypertension
- Other medical conditions deterring protocolled investigation and follow-up
- Other medical conditions affecting 5-yrs prognosis (cancer, pulmonary disease)
- Severely reduced image-quality (echocardiography and MRI)
Key Trial Info
Start Date :
January 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT03422770
Start Date
January 9 2018
End Date
June 30 2020
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Circulation and Medical Imaging
Trondheim, Norway